Tumor antigen presentation via major histocompatibility complex class II (MHC Class II antigen presentation)

Tumor antigen presentation via major histocompatibility complex (MHC) class II refers to the process by which tumor-derived antigens are processed and displayed on the surface of cells in association with MHC class II molecules. This presentation is crucial for the activation of CD4+ T helper (TH) cells, which play a central role in orchestrating adaptive immune responses against tumors. Effective anti-tumor immunity often requires robust activation through this pathway. Most human cancers evade detection partly due to low/no intrinsic expression/functionality along this axis. Enhancing antigen presentation through major histocompatibility complex class II remains a promising avenue for next-generation cancer immunotherapies.

Other names

MHC-II antigen presentationTumor antigen presentation via MHC-II

Presentation of tumor-derived peptides to CD4+ T helper cells via MHC class II molecules, leading to T cell activation and anti-tumor immune responses.